New drug formulations of colony-stimulating factors in oncohematology
The use of colony-stimulating factors became an autonomous approach in complex supportive care of blood tumors. By indications of granulocyte colony-stimulating factor (G-CSF) it is possible to reduce of neutropenic period, perform an optimal timing of therapy, decrease a number of infection complic...
Saved in:
| Main Authors: | T. T. Valiev, R. R. Fatkhullin, Yu. E. Ryabukhina, P. A. Zeynalova |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
ABV-press
2023-03-01
|
| Series: | Онкогематология |
| Subjects: | |
| Online Access: | https://oncohematology.abvpress.ru/ongm/article/view/805 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Granulocyte colony-stimulating factor-associated aortitis in a woman with breast cancer: a case report
by: Nana Matsumoto, et al.
Published: (2022-08-01) -
Drug-induced aortitis of the subclavian artery caused by pegfilgrastim: a case report
by: Hikari Jimbo, et al.
Published: (2021-08-01) -
Microarrays: a new era in development of oncohematology
by: Ye. A. Nikitin, et al.
Published: (2022-11-01) -
Pegfilgrastim-induced vasculitis of the subclavian and basilar artery complicated by subarachnoid hemorrhage in a breast cancer patient: a case report and review of the literature
by: Yukiko Seto, et al.
Published: (2022-08-01) -
Prevention of neutropenia during chemotherapy by prolonged myelostimulatory preparations
by: V. V. Ptushkin, et al.
Published: (2015-06-01)